Sign up for the QMED & MD+DI Daily newsletter.
Medical Device Giants Shape Neurodevice Market
January 1, 2007
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Medical Device Giants Shape Neurodevice Market")
BUSINESS PLANNING & TECHNOLOGY DEVELOPMENT
Major medical device companies, including Johnson & Johnson Inc. (New Brunswick, NJ), Boston Scientific Corp. (Natick, MA), St. Jude Medical Inc. (St. Paul, MN), and Medtronic Inc. (Minneapolis), are jostling for position in the emerging neurodevice sector. These companies profited from the explosion of medical devices for cardio indications and see similar expansion potential for neurodevices over the next 10 years.
The participation of these companies will continue to shape the development and maturation of the neurodevice market in the following ways.
Over the past several years, major medical device companies have made heavy investments in neurodevice start-ups through private financings and corporate acquisitions.
Long-term investment in technology for implantable devices made by big companies translates into shorter development times for new companies that are more agile in translating technology into innovative products.
Large companies with established sales and training teams have primed the physician and patient market, reducing implantation bias. Copyright ©2007 MX
You May Also Like
